Cabazitaxel: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Cabazitaxel. Educational only — not medical advice.

Labeled uses

JEVTANA® is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimen.

Source: FDA labeling via NIH DailyMed (set de3d9c26…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.